SCHEMBL25540429

SCHEMBL25540429

Cc1ccc2c(-c3ccccc3)c3ccccc3c(-c3ccc(-c4ccc5nc(C)n(-c6ccccc6)c5c4)cc3)c2c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.48
MAPK1 P28482 1/20 0.48
ALDH1A1 P00352 7/20 0.42
POLB P06746 1/20 0.42
DHODH Q02127 1/20 0.41
AVPR1A P37288 1/20 0.41
CYP1A2 P05177 1/20 0.40
PDE10A Q9Y233 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PIK3CD O00329 1/20 0.39
PIK3CA P42336 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 2/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17932824 0.93 MAPK1 (0.55) HTTMAPK1ALDH1A1AVPR1ACYP1A2
SCHEMBL19310492 0.93 MAPK1 (0.55) HTTMAPK1ALDH1A1AVPR1ACYP1A2
SCHEMBL24812208 0.92 MAPK1 (0.51) HTTMAPK1ALDH1A1AVPR1ACYP1A2
SCHEMBL21515507 0.88 MAPK1 (0.50) HTTMAPK1ALDH1A1AVPR1ACYP1A2
SCHEMBL13042802 0.86 ALDH1A1 (0.46) ALDH1A1POLBDHODHPIK3CDPIK3CA
SCHEMBL1104832 0.85 MAPK1 (0.65) HTTMAPK1ALDH1A1AVPR1ACYP1A2
SCHEMBL13042850 0.85 ESR1 (0.46) ALDH1A1DHODHPIK3CDPIK3CAKDM4E
SCHEMBL24812214 0.85 MAPK1 (0.49) HTTMAPK1ALDH1A1AVPR1ACYP1A2
SCHEMBL24674116 0.84 MAPK1 (0.58) HTTMAPK1ALDH1A1POLBHSD17B10
SCHEMBL24674392 0.84 MAPK1 (0.58) HTTMAPK1ALDH1A1POLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 US disclosed
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND CRY1, CYP1A1, NQO1 HTT 1229/4885MAPK1 1922/4885ALDH1A1 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.